Biomaterials, Journal Year: 2025, Volume and Issue: unknown, P. 123422 - 123422
Published: May 1, 2025
Language: Английский
Biomaterials, Journal Year: 2025, Volume and Issue: unknown, P. 123422 - 123422
Published: May 1, 2025
Language: Английский
Colloids and Surfaces B Biointerfaces, Journal Year: 2025, Volume and Issue: unknown, P. 114668 - 114668
Published: March 1, 2025
Language: Английский
Citations
0Materials Today Bio, Journal Year: 2025, Volume and Issue: 32, P. 101781 - 101781
Published: April 17, 2025
Depression and cognitive disorders remain major challenges in healthcare, with conventional treatments often facing limitations such as slow onset, side effects, poor drug delivery to the brain. Biomimetic nanodelivery systems, including nanozymes, cell membrane-based exosomes, have emerged promising solutions these issues. These systems leverage natural biological processes enhance targeting, improve bioavailability, regulate complex pathways. Nanoenzymes, their catalytic properties, offer antioxidant anti-inflammatory benefits, while membranes exosomes provide efficient targeting immune evasion. However, remain, immaturity of large-scale production techniques, stability concerns, incomplete understanding mechanisms action. Moreover, long-term safety, pharmacokinetics, toxicity require further investigation. Despite obstacles, potential biomimetic revolutionize depression treatment is significant. Future research should focus on optimizing preparation, improving release, ensuring clinical safety. Multidisciplinary collaboration will be essential for advancing from laboratory practice, offering new therapeutic avenues other neurological disorders.
Language: Английский
Citations
0Biomaterials, Journal Year: 2025, Volume and Issue: unknown, P. 123422 - 123422
Published: May 1, 2025
Language: Английский
Citations
0